Lloyds Banking Group Plc American Depositary Shares vs uniQure N.V. Ordinary Shares — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.65 (market cap $79.61B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 54.9× uniQure N.V. Ordinary Shares's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 3.99% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 3 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| LYG | QURE | |
|---|---|---|
Market Cap | $79.61B | $1.45B |
Volume | 13,734,654 | 3,323,243 |
Sector | Financials | Health |
52-Week High | $6.28 | $70.59 |
52-Week Low | $4.44 | $9.03 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $102.02B | $707.46M |
Dividend Yield | 3.99% | — |
Signals from Pluang's Aura AI — not financial advice
Lloyds Banking Group (LYG) trades at $5.50, up 0.73% on the day, with a bearish technical signal from moving averages. The company reported strong profitability with a net income margin of 24.5% and has beaten earnings estimates in two of the last three quarters. Recent news highlights its 2030 growth plan emphasizing AI and efficiency, with potential acquisition interest in Aldermore.
The outlook is mixed: analyst consensus is bullish (58% buy ratings), but technicals and a recent earnings miss pose near-term risks. Upside catalysts include strategic investments and resilient UK consumers, while risks involve economic sensitivity and competitive pressures. The stock's valuation appears reasonable with a P/E of 12.98.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →